News

• New Recombinant XYNTHA Now Available for Patients with Hemophilia A

  (posted on 08/09/2008)

• BioCryst Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis

  (posted on 04/09/2008)

• Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

  (posted on 04/09/2008)

• Alseres Pharmaceuticals Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing

  (posted on 28/08/2008)

• Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection

  (posted on 28/08/2008)

• Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

  (posted on 28/08/2008)

• New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

  (posted on 27/08/2008)

• Sanofi-aventis News

  (posted on 31/07/2008)

• Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease

  (posted on 31/07/2008)

• Memory Pharmaceuticals Presents Positive Preclinical Data for MEM 68626 at ICAD 2008

  (posted on 30/07/2008)

Result Page: 1 2 3 4 5 6 7 8 9 10 Next